Published in Breast Cancer Res on November 13, 2002
miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors. Mol Cell (2010) 3.27
Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). J Natl Cancer Inst (2006) 2.25
HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype. J Clin Invest (2010) 2.00
Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers. EMBO Mol Med (2011) 1.68
Transcriptional regulation of BRCA1 expression by a metabolic switch. Nat Struct Mol Biol (2010) 1.25
Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer. Cell Cycle (2013) 1.23
Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation. Proc Natl Acad Sci U S A (2014) 1.22
Genetic and epigenetic silencing of the beclin 1 gene in sporadic breast tumors. BMC Cancer (2010) 1.20
miR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer. Breast Cancer Res (2014) 1.15
MicroRNAs as therapeutic targets in chemoresistance. Drug Resist Updat (2013) 1.11
Charity begins at home: non-coding RNA functions in DNA repair. Nat Rev Mol Cell Biol (2013) 1.05
Decreased BECN1 mRNA Expression in Human Breast Cancer is Associated with Estrogen Receptor-Negative Subtypes and Poor Prognosis. EBioMedicine (2015) 1.04
Tumour suppressor genes in chemotherapeutic drug response. Biosci Rep (2012) 0.99
Redox-dependent Brca1 transcriptional regulation by an NADH-sensor CtBP1. Oncogene (2010) 0.96
A genomewide screen for suppressors of Alu-mediated rearrangements reveals a role for PIF1. PLoS One (2012) 0.96
Transcriptional down-regulation of Brca1 and E-cadherin by CtBP1 in breast cancer. Mol Carcinog (2011) 0.94
The role of the breast cancer susceptibility gene 1 (BRCA1) in sporadic epithelial ovarian cancer. Reprod Biol Endocrinol (2003) 0.86
Estrogen receptor (ER) beta or p53 attenuates ERalpha-mediated transcriptional activation on the BRCA2 promoter. J Biol Chem (2008) 0.85
Frequent promoter hypermethylation and expression reduction of the glucocorticoid receptor gene in breast tumors. Epigenetics (2014) 0.84
Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers. Cell Oncol (Dordr) (2015) 0.84
Turnover of BRCA1 involves in radiation-induced apoptosis. PLoS One (2010) 0.83
Gain of function mutant p53 proteins cooperate with E2F4 to transcriptionally downregulate RAD17 and BRCA1 gene expression. Oncotarget (2015) 0.82
Decreased expression of BRCA1 in SK-BR-3 cells is the result of aberrant activation of the GABP Beta promoter by an NRF-1-containing complex. Mol Cancer (2011) 0.82
RNF126 promotes homologous recombination via regulation of E2F1-mediated BRCA1 expression. Oncogene (2015) 0.81
CtBP1 is expressed in melanoma and represses the transcription of p16INK4a and Brca1. J Invest Dermatol (2013) 0.81
Characterization of a negative transcriptional element in the BRCA1 promoter. Breast Cancer Res (2007) 0.81
MicroRNA deregulation in triple negative breast cancer reveals a role of miR-498 in regulating BRCA1 expression. Oncotarget (2016) 0.80
Detoxification: a novel function of BRCA1 in tumor suppression? Toxicol Sci (2011) 0.80
Susceptibility to DNA damage as a molecular mechanism for non-syndromic cleft lip and palate. PLoS One (2013) 0.79
DNA stabilization by the upregulation of estrogen signaling in BRCA gene mutation carriers. Drug Des Devel Ther (2015) 0.78
Expression microarray identifies the unliganded glucocorticoid receptor as a regulator of gene expression in mammary epithelial cells. BMC Cancer (2014) 0.78
Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression. Cell Death Dis (2016) 0.77
Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression. Cancer Prev Res (Phila) (2011) 0.76
HTLV-1 Tax oncoprotein inhibits the estrogen-induced-ER α-Mediated BRCA1 expression by interaction with CBP/p300 cofactors. PLoS One (2014) 0.76
Interactions Between Ataxia Telangiectasia Mutated Kinase Inhibition, Poly(ADP-ribose) Polymerase-1 Inhibition and BRCA1 Status in Breast Cancer Cells. J Cancer Prev (2014) 0.75
Effect of TPA and HTLV-1 Tax on BRCA1 and ERE controlled genes expression. Cell Cycle (2017) 0.75
The potential role of miRNAs in therapy of breast and ovarian cancers associated with BRCA1 mutation. Hered Cancer Clin Pract (2017) 0.75
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science (1994) 36.53
Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol (1997) 10.61
Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell (2002) 9.61
Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet (1999) 8.17
BRCA1 mutations in primary breast and ovarian carcinomas. Science (1994) 6.81
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet (1996) 6.43
The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell (1999) 6.08
Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc Natl Acad Sci U S A (1998) 5.34
Stromal effects on mammary gland development and breast cancer. Science (2002) 5.22
Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J Cell Biol (1994) 3.68
Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J Cell Biol (1992) 3.29
BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat Genet (2002) 3.11
Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet (1995) 2.91
Laminin mediates tissue-specific gene expression in mammary epithelia. J Cell Biol (1995) 2.83
Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat Genet (1999) 2.83
Think globally, act locally: the making of a mouse mammary gland. Genes Dev (1998) 2.34
Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene (1999) 2.09
The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nat Genet (1995) 2.02
Suppression of mammary epithelial cell differentiation by the helix-loop-helix protein Id-1. Mol Cell Biol (1995) 1.97
BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations. J Cell Biol (2001) 1.96
Direct DNA binding by Brca1. Proc Natl Acad Sci U S A (2001) 1.94
Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J Cell Biol (1995) 1.91
Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach. Proc Natl Acad Sci U S A (2001) 1.90
BRCA1 transcriptionally regulates genes involved in breast tumorigenesis. Proc Natl Acad Sci U S A (2002) 1.89
Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res (1997) 1.79
Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells. Oncogene (1998) 1.74
Accelerated apoptosis in the Timp-3-deficient mammary gland. J Clin Invest (2001) 1.71
Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. Proc Natl Acad Sci U S A (1996) 1.70
Complex regulation of the BRCA1 gene. J Biol Chem (1997) 1.68
Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev (1995) 1.61
Stat5 as a target for regulation by extracellular matrix. J Biol Chem (1995) 1.61
CpG methylation within the 5' regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site. Oncogene (1998) 1.58
Immunolocalization of BRCA1 protein in normal breast tissue and sporadic invasive ductal carcinomas: a correlation with other biological parameters. Histopathology (1999) 1.57
Characterization of BCE-1, a transcriptional enhancer regulated by prolactin and extracellular matrix and modulated by the state of histone acetylation. Mol Cell Biol (1998) 1.52
Isolation and characterisation of the NBR2 gene which lies head to head with the human BRCA1 gene. Hum Mol Genet (1997) 1.50
Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens. Carcinogenesis (2000) 1.46
Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Res (1995) 1.43
Promoter-region hypermethylation and gene silencing in human cancer. Curr Top Microbiol Immunol (2000) 1.38
Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues. Dev Biol (1997) 1.32
Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Cell Growth Differ (1996) 1.32
Id-1, ITF-2, and Id-2 comprise a network of helix-loop-helix proteins that regulate mammary epithelial cell proliferation, differentiation, and apoptosis. J Biol Chem (2001) 1.31
Transcriptional repression of BRCA1 by aberrant cytosine methylation, histone hypoacetylation and chromatin condensation of the BRCA1 promoter. Nucleic Acids Res (2000) 1.28
BRCA1 expression is not directly responsive to estrogen. Oncogene (1997) 1.24
Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region. Oncogene (1998) 1.21
BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen. Oncogene (1996) 1.19
Regulation of mouse mammary gland development and tumorigenesis by the ERBB signaling network. J Mammary Gland Biol Neoplasia (2001) 1.18
An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancers. Int J Cancer (1998) 1.17
Brca1 and Brca2 expression patterns in mitotic and meiotic cells of mice. Oncogene (1998) 1.17
Regulation of BRCA1 expression by the Rb-E2F pathway. J Biol Chem (2000) 1.17
Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases. Clin Cancer Res (1999) 1.16
The 5' end of the BRCA1 gene lies within a duplicated region of human chromosome 17q21. Oncogene (1996) 1.11
Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers. Int J Cancer (2000) 1.11
Distinct transcription start sites generate two forms of BRCA1 mRNA. Hum Mol Genet (1995) 1.08
Functional analysis of CpG methylation in the BRCA1 promoter region. Oncogene (2001) 1.06
Synapse-specific and neuregulin-induced transcription require an ets site that binds GABPalpha/GABPbeta. Genes Dev (1998) 1.05
Positive regulation of the BRCA1 promoter. J Biol Chem (1999) 1.05
Estrogen upregulation of BRCA1 expression with no effect on localization. Mol Carcinog (1998) 1.05
Regulation of BRCA1 by protein degradation. Oncogene (1999) 1.03
A CREB site in the BRCA1 proximal promoter acts as a constitutive transcriptional element. Oncogene (2001) 1.02
BRCA1 expression levels predict distant metastasis of sporadic breast cancers. Int J Cancer (1999) 1.01
Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers. Int J Cancer (1998) 1.01
Regional methylation of the 5' end CpG island of BRCA1 is associated with reduced gene expression in human somatic cells. FASEB J (2000) 0.98
Prognostic significance of BRCA1 expression in Japanese sporadic breast carcinomas. Cancer (2001) 0.98
Transcription of BRCA1 is dependent on the formation of a specific protein-DNA complex on the minimal BRCA1 Bi-directional promoter. J Biol Chem (1999) 0.96
Repression of BRCA1 through a feedback loop involving p53. J Biol Chem (2000) 0.96
The BRCA1 and BRCA2 breast cancer genes. Curr Opin Oncol (1997) 0.96
Loss of nuclear BRCA1 expression in breast cancers is associated with a highly proliferative tumor phenotype. Cancer Genet Cytogenet (1998) 0.96
Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene. Int J Cancer (1999) 0.95
A sporadic breast tumor with a somatically acquired complex genomic rearrangement in BRCA1. Genes Chromosomes Cancer (2000) 0.91
GA-binding protein alpha/beta is a critical regulator of the BRCA1 promoter. Oncogene (2000) 0.91
Isolation of the murine Nbr1 gene adjacent to the murine Brca1 gene. Genomics (1996) 0.88
Expression of BRCA1 gene in ewe mammary epithelial cells during pregnancy: regulation by growth hormone and steroid hormones. Eur J Endocrinol (2001) 0.85
Identification of a possible somatic BRCA1 mutation affecting translation efficiency in an early-onset sporadic breast cancer patient. J Natl Cancer Inst (1998) 0.84
Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinoma. Int J Oncol (1998) 0.84
Laminin-rich extracellular matrix association with mammary epithelial cells suppresses Brca1 expression. Cell Death Differ (2000) 0.81
Prolactin-dependent up-regulation of BRCA1 expression in human breast cancer cell lines. Biochem Biophys Res Commun (1999) 0.81
Identification of a novel transcriptional repressor element located in the first intron of the human BRCA1 gene. Oncogene (2001) 0.81
Expression of BRCA1, NBR1 and NBR2 genes in human breast cancer cells. Folia Biol (Praha) (2001) 0.77
Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell (2002) 5.58
Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression. Cancer Res (2004) 1.90
Collagen-IV and laminin-1 regulate estrogen receptor alpha expression and function in mouse mammary epithelial cells. J Cell Sci (2003) 1.27
The CD34-related molecule podocalyxin is a potent inducer of microvillus formation. PLoS One (2007) 1.25
The anti-adhesive mucin podocalyxin may help initiate the transperitoneal metastasis of high grade serous ovarian carcinoma. Clin Exp Metastasis (2012) 1.13
Podocalyxin: a marker of blasts in acute leukemia. Am J Clin Pathol (2005) 1.06
Progressive changes in Met-dependent signaling in a human ovarian surface epithelial model of malignant transformation. Exp Cell Res (2004) 1.04
ETV6-NTRK3-mediated breast epithelial cell transformation is blocked by targeting the IGF1R signaling pathway. Cancer Res (2010) 1.02
The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression. Differentiation (2007) 1.02
Cofilin-mediated F-actin severing is regulated by the Rap GTPase and controls the cytoskeletal dynamics that drive lymphocyte spreading and BCR microcluster formation. J Immunol (2011) 1.00
Expression of activated M-Ras in a murine mammary epithelial cell line induces epithelial-mesenchymal transition and tumorigenesis. Oncogene (2004) 0.98
Neopetrosiamides, peptides from the marine sponge Neopetrosia sp. that inhibit amoeboid invasion by human tumor cells. Org Lett (2005) 0.95
Preventing the activation or cycling of the Rap1 GTPase alters adhesion and cytoskeletal dynamics and blocks metastatic melanoma cell extravasation into the lungs. Cancer Res (2010) 0.95
Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases. Int J Gynecol Pathol (2010) 0.93
The tumor invasion inhibitor dihydromotuporamine C activates RHO, remodels stress fibers and focal adhesions, and stimulates sodium-proton exchange. Cancer Res (2004) 0.88
Opposing roles for CD34 in B16 melanoma tumor growth alter early stage vasculature and late stage immune cell infiltration. PLoS One (2011) 0.86
The role of the breast cancer susceptibility gene 1 (BRCA1) in sporadic epithelial ovarian cancer. Reprod Biol Endocrinol (2003) 0.86
Epithelio-mesenchymal transition in a neoplastic ovarian epithelial hybrid cell line. Differentiation (2004) 0.84
Strongylophorine-26, a Rho-dependent inhibitor of tumor cell invasion that reduces actin stress fibers and induces nonpolarized lamellipodial extensions. Mol Cancer Ther (2005) 0.83
Organellar (Na+, K+)/H+ exchanger NHE7 regulates cell adhesion, invasion and anchorage-independent growth of breast cancer MDA-MB-231 cells. Oncol Rep (2011) 0.82
Na+/H+ exchanger regulatory factor-1 is a hematopoietic ligand for a subset of the CD34 family of stem cell surface proteins. Stem Cells (2006) 0.82
Combining chemical genomics screens in yeast to reveal spectrum of effects of chemical inhibition of sphingolipid biosynthesis. BMC Microbiol (2009) 0.81
Differential effects of cellular fibronectin and plasma fibronectin on ovarian cancer cell adhesion, migration, and invasion. In Vitro Cell Dev Biol Anim (2003) 0.80
Avinosol, a meroterpenoid-nucleoside conjugate with antiinvasion activity isolated from the marine sponge Dysidea sp. Org Lett (2006) 0.80
Microenvironmental regulation of BRCA1 gene expression by c-Jun and Fra2 in premalignant human ovarian surface epithelial cells. Mol Cancer Res (2013) 0.80
Regulation of the BRCA1 promoter in ovarian surface epithelial cells and ovarian carcinoma cells. FEBS Lett (2007) 0.78
Strongylophorine-26, a new meroditerpenoid isolated from the marine sponge Petrosia (Strongylophora) corticata that exhibits anti-invasion activity. J Nat Prod (2004) 0.78
Release of membrane-bound vesicles and inhibition of tumor cell adhesion by the peptide Neopetrosiamide A. PLoS One (2010) 0.77
The invasion inhibitor sarasinoside A1 reverses mesenchymal tumor transformation in an E-cadherin-independent manner. Mol Cancer Res (2013) 0.77
Chemical synthesis and biological activity of the neopetrosiamides and their analogues: revision of disulfide bond connectivity. J Am Chem Soc (2010) 0.77
Strongylophorine-26, an inhibitor of cancer cell Invasion: SAR revealed by synthesis of analogues. J Nat Prod (2007) 0.76
Erratum: Toll-like receptor ligands sensitize B-cell receptor signalling by reducing actin-dependent spatial confinement of the receptor. Nat Commun (2015) 0.76
Synthesis and biological studies of neopetrosiamides as inhibitors of cancer cell invasion. Org Biomol Chem (2013) 0.75
The small molecule genkwanine M induces single mode, mesenchymal tumor cell motility. Exp Cell Res (2013) 0.75